NUS
Nu Skin EnterprisesCAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The Q2 follow-up is mixed-to-negative: adjusted EPS was near the prior midpoint, but revenue came below the prior guidance range and full-year guidance was reset lower. The share-price anchor is $4.85 on August 12, but no trustworthy source in the packet attributes the post-print move to results or guidance. Analyst target changes, estimate revisions, options, short interest, employee ratings, and social coverage are unavailable; this remains a low-coverage monitoring setup.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The company expects Q3 revenue of $310-$340 million and adjusted EPS of $0.10-$0.20. Revenue stabilization and delivery near the outlook range could support the shares, while another shortfall would reinforce the revised-down thesis. [#SEC-8K-2026-08-10]
Q2 revenue declined 17.1% year over year to $320.1 million, below the prior $330-$360 million outlook range; customers, paid affiliates, and sales leaders also fell 14%, 8%, and 9%. Management reduced 2026 revenue guidance to $1.28-$1.35 billion and adjusted EPS guidance to $0.70-$0.90. [#SEC-8K-2026-08-10]
Management cited continued Prysm iO rollout and preparations for a formal India launch in late 2026, but affiliate monetization, subscriptions, and demand recovery remain unproven. [#SEC-8K-2026-08-10][#SEC-8K-2026-05-07]
Recommendation
No formal recommendation provided.

